tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life Group Executes Share Buyback Program

Story Highlights
  • Venture Life Group PLC has acquired 52,690 ordinary shares as part of its share buyback program.
  • The share buyback impacts the total voting rights, now at 127,448,304, affecting shareholder calculations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life Group Executes Share Buyback Program

Claim 50% Off TipRanks Premium and Invest with Confidence

Venture Life ( (GB:VLG) ) just unveiled an update.

Venture Life Group PLC has executed a share buyback program, acquiring 52,690 ordinary shares at a volume-weighted average price of 61.82 pence per share. These shares will be held as treasury shares, impacting the total number of voting rights in the company, which now stands at 127,448,304. This move is part of the company’s ongoing efforts to manage its capital structure and may influence shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group PLC is an international consumer self-care company headquartered in the UK, focusing on the commercialisation of products for the global self-care market. Their product portfolio includes Balance Activ for women’s intimate healthcare, Earol® for ENT care, Lift and Glucogel for energy and glucose management, and Health & Her for hormonal lifecycle support. These products are available through health & beauty stores, pharmacies, grocery multiples, and e-commerce channels, and are sold globally. In the UK, Ireland, and the USA, the company supplies directly to retailers, while in other regions, they utilize international distribution partners.

Average Trading Volume: 174,183

Technical Sentiment Signal: Buy

Current Market Cap: £78.78M

See more data about VLG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1